Role of glucose and ketone bodies in the metabolic control of experimental brain cancer. - Wikidata - wikimedia - TriplyDB

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

http://www.wikidata.org/entity/Q34542313

about

Is there a role for carbohydrate restriction in the treatment and prevention of cancer?Cancer as a metabolic disease Targeting energy metabolism in brain cancer: review and hypothesis The Efficacy of Ketogenic Diet and Associated Hypoglycemia as an Adjuvant Therapy for High-Grade Gliomas: A Review of the Literature Fasting enhances the response of glioma to chemo- and radiotherapy Dietary and pharmacological modification of the insulin/IGF-1 system: exploiting the full repertoire against cancer The Role of Glucose Modulation and Dietary Supplementation in Patients With Central Nervous System Tumors Influence of caloric restriction on constitutive expression of NF-κB in an experimental mouse astrocytoma The ketogenic diet is an effective adjuvant to radiation therapy for the treatment of malignant glioma Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.Associations between prediagnostic blood glucose levels, diabetes, and glioma.Influence of a ketogenic diet, fish-oil, and calorie restriction on plasma metabolites and lipids in C57BL/6J mice.Tumor Cells Growth and Survival Time with the Ketogenic Diet in Animal Models: A Systematic Review Cerebral metabolic adaptation and ketone metabolism after brain injury.Dietary energy availability affects primary and metastatic breast cancer and metformin efficacy.Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse.Roles of caloric restriction, ketogenic diet and intermittent fasting during initiation, progression and metastasis of cancer in animal models: a systematic review and meta-analysis.The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma.Ketone ester effects on metabolism and transcription.Ketogenic diets as an adjuvant cancer therapy: History and potential mechanism Ketogenic diets: from cancer to mitochondrial diseases and beyond.Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.Growth of human gastric cancer cells in nude mice is delayed by a ketogenic diet supplemented with omega-3 fatty acids and medium-chain triglycerides.Carbohydrate restriction, prostate cancer growth, and the insulin-like growth factor axis The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer.Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans.The glucose ketone index calculator: a simple tool to monitor therapeutic efficacy for metabolic management of brain cancer.A unique four-hub protein cluster associates to glioblastoma progression.Glucose deprivation in tuberous sclerosis complex-related tumors.Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.Anti-Tumor Effects of Ketogenic Diets in Mice: A Meta-Analysis.Ketogenic diets, mitochondria, and neurological diseases.Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.Long-term High Fat Ketogenic Diet Promotes Renal Tumor Growth in a Rat Model of Tuberous Sclerosis.Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.Short-term calorie and protein restriction provide partial protection from chemotoxicity but do not delay glioma progression.Mitochondrial Dysfunction in Gliomas: Pharmacotherapeutic Potential of Natural Compounds.The effects of varying dietary carbohydrate and fat content on survival in a murine LNCaP prostate cancer xenograft model.

P2860

Q21245058-E2F6CF66-4032-41B1-B31C-075811675820 Q21245061-F6A988B5-018B-44A0-AD78-EB4F75D79A70 Q24537119-13854A9E-D691-499F-B7D9-84DF1389B48F Q26800604-FCB4B171-AB90-46CC-A184-772DCD4398AD Q27320014-6D0028E1-E2BD-4DCB-B9F3-29CE1DAB86F1 Q28069088-569C6F89-73A3-4C6A-A9FA-1EA56130602B Q28087476-8DC1D977-3087-4512-A90D-F3E908E282F9 Q28477560-D3E75F15-2132-4AFE-B33C-5938E52B0F40 Q28730187-AF22A0F9-C71C-4B7C-8417-9E7FE8F97205 Q33562229-6D570B36-EA07-4A38-A9B4-1F1B15C636EE Q33684013-CEE01AE7-1537-4F3C-82D9-0C1B31363739 Q33718016-2E585976-96C5-45A3-99CE-3991AAD663B3 Q33743850-58D8A2DB-0B6D-4603-9754-6E829B1F6CBF Q33802454-67D13E57-D44E-48DD-B66C-93ED2A5037E4 Q33926391-8ACA5C35-72C0-49F2-A4FC-8539ED95DB5A Q33972116-58B999BC-CCA6-48C7-AEE5-2DDC592789CA Q34014571-A5511928-4CD5-42F1-BA09-31DDC730F58E Q34042713-40FF9C97-FAE4-4486-9D2F-E81635D1D0A0 Q34174680-7CEDAF82-BAF6-4A78-A6B8-25391C31350D Q34238624-225DFD42-D084-4EA3-974B-DBFF778B2BD6 Q34432306-2722BFB5-B3CE-4BBC-8E87-C6A5F573BDBB Q34509699-885A5C62-0906-4908-B6F2-AE2A1BC6BD6C Q34558255-E46B048F-8697-4171-B70E-6DC0E994D1C5 Q34576016-890227DB-3400-4C79-A9FC-11D171C488AF Q34591316-B1212EE0-C497-4A89-A1BA-AFAF48DC7A04 Q34713132-73A01403-BE97-42DE-ABCF-4393C486A9F8 Q34766593-B375655E-CD4D-40F5-AECF-59F0B2669305 Q34804059-36C8A5A4-5B27-4A67-891F-6A4199ED61CE Q35200938-BC180B0A-56A4-4DA0-B864-2DBF96CBA77A Q35210961-FA4D6EDC-FEBA-4EB9-B250-E9687F54632C Q35560024-4270673F-FA39-435A-ADD3-E556060C9DAC Q35656317-9F21F6E2-B8A4-4D54-8C1B-EBAD979B6AE4 Q36012197-A5095E2F-09D8-44C4-A564-1907D9805E08 Q36196765-4FA05880-2FE7-4FC6-9211-B19A50876C5B Q36351072-5B0CA3BD-6755-418F-B622-E82E7A3D4F64 Q36595635-9DFDAA94-C8CC-43AC-9E5C-1F6A9044281C Q37086200-BF572857-7D2C-4049-A33A-D0F5FCFAE485 Q37146692-F98CC093-85FB-4FC7-8BDF-CA64A56412EB Q37168749-8B57489A-070E-4CEA-B8B5-283CC3F9F713 Q37173979-1E459CBE-BB57-49BE-89D9-1136D45F4D47

P2860

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

http://www.wikidata.org/entity/Q34542313

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@ast

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@en

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@nl

type

label

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@ast

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@en

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@nl

prefLabel

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@ast

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@en

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@nl

P1433

Q34542313-B2745C2A-4CF6-422E-BFED-4B7BA2AD116B

P1476

Q34542313-FEE064D9-897D-4187-8BEB-357185EB2FA1

P2093

Q34542313-27836D2A-86E2-4093-96EB-F7DBF5E0BBAC

Q34542313-4B66F1EB-38EE-4B46-B8D9-81D0FCA03EED

Q34542313-A701C975-5E5B-4C6A-BAB9-B36F46C51BFF

Q34542313-F2C61B82-1822-4896-B7E5-E7839B7B6462

P2860

Q34542313-007F70A9-42FC-429E-BB01-E1C2DB5D2B93

Q34542313-0143A52E-B3C1-4BBB-85AC-83268E0E8A1D

Q34542313-019C05DD-1C88-4E42-82C5-728AFBC7DC19

Q34542313-14470D6F-4E41-4A52-B0FC-2D68F3F49BBA

Q34542313-170E4F9B-F126-4C60-A7BC-A30D519F87A7

Q34542313-1C061E96-366B-4050-9E9D-DF6D4F47200C

Q34542313-1DAC605C-08A3-4C0E-8A1E-3709569B163A

Q34542313-22CDE584-8E27-4122-90A0-E43766455ECE

Q34542313-2AA2E02B-1C51-4FC0-AF1D-60A095511195

Q34542313-2C793805-8268-4784-8F2B-D4A5F28D89D2

P2888

Q34542313-0EF12618-0A20-4F4E-B186-6FBEAF6A8BE4

P304

Q34542313-01A63C69-D7CC-42D7-A3D5-B9421452F756

P31

Q34542313-FC858F31-8956-451C-8B01-C425A30B419F

P356

Q34542313-21BB1464-DD26-4803-9F87-FAD954C9299A

P407

Q34542313-6B99CE0B-7001-439C-8B69-A1D0BA8E73AD

P433

Q34542313-44E43469-BFEA-4BBD-89BF-56AF24CCD669

P478

Q34542313-BCBD5ACD-E67A-4EA5-9069-ABB0B491B7AB

P50

Q34542313-F1DA320D-BF7B-49AF-951D-0618BA1BFDC1

P577

Q34542313-04E57677-E65E-459E-BCD0-007AD25EFA1E

P5875

Q34542313-9FFB6757-0C3C-4466-976C-F7111A58AF37

P6179

Q34542313-0C5F8DED-151D-4F0C-9C6D-0D9DD4F0A188

P698

Q34542313-77261B32-9C76-42EE-8F4E-8F37ECF08A7E

P932

Q34542313-CC7811D9-9FDF-41B4-A352-E868C3AE6FBE

P356

P1433

British Journal of Cancer

P1476

Role of glucose and ketone bodies in the metabolic control of experimental brain cancer.

@en

P2093

M M El-Abbadi

http://www.w3.org/2001/XMLSchema#string

P Mukherjee

http://www.w3.org/2001/XMLSchema#string

R McGowan

http://www.w3.org/2001/XMLSchema#string

T M Sanderson

http://www.w3.org/2001/XMLSchema#string

P2860

Brain metabolism during fasting

Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death

Altered alveolar macrophage function in calorie-restricted rats

On the Origin of Cancer Cells

N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours

A unique glucose-dependent apoptotic pathway induced by c-Myc

Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis.

Current therapy for brain tumors: back to the future.

Caloric restriction and experimental carcinogenesis.

Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction.

P2888

P304

1375-1382

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6601269

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P50

Thomas N Seyfried

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9071870

http://www.w3.org/2001/XMLSchema#string

P6179

1029071613

http://www.w3.org/2001/XMLSchema#string

P698

14520474

http://www.w3.org/2001/XMLSchema#string

P932

2394295

http://www.w3.org/2001/XMLSchema#string